Lomond Therapeutics Holdings, Inc.
Clinical trials sponsored by Lomond Therapeutics Holdings, Inc., explained in plain language.
-
First step for new AML drug: safety check in healthy volunteers
Knowledge-focused CompletedThis study tested a new drug called ZE46-0134 in 112 healthy adults to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. Since this was the first time the drug was given to people, the main goal was to check for side…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New drug ZE50-0134 passes first safety check in healthy people
Knowledge-focused CompletedThis was a first-in-human study to see if ZE50-0134 is safe and how it behaves in the body. 104 healthy adults received either the drug or a placebo. The study also looked at how the drug interacts with other medications like rabeprazole and itraconazole. Since this was only in h…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC